Duncan Gallagher is of Health Catalyst, Inc.. Currently has a direct ownership of 76,937 shares of HCAT, which is worth approximately $597,800. The most recent transaction as insider was on Sep 01, 2024, when has been sold 2,414 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.9K
3.24% 3M change
43.23% 12M change
Total Value Held $597,800

Duncan Gallagher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2024
BUY
Grant, award, or other acquisition
-
2,414 Added 3.04%
76,937 Common Stock
Jun 13 2024
BUY
Grant, award, or other acquisition
-
20,807 Added 21.83%
74,523 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
18,311 Added 25.42%
53,716 Common Stock
Aug 19 2022
BUY
Open market or private purchase
$76,758 $11.63 p/Share
6,600 Added 15.71%
35,405 Common Stock
Aug 18 2022
BUY
Open market or private purchase
$98,196 $11.69 p/Share
8,400 Added 22.58%
28,805 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
11,677 Added 36.4%
20,405 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
3,285 Added 27.35%
8,728 Common Stock
DG

Duncan Gallagher

South Jordan, UT

Track Institutional and Insider Activities on HCAT

Follow Health Catalyst, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT